MedicaidPrior AuthMedium impact
Pharmacy Program Updates January 2025
Alaska Medicaid·AK · Pharmacy, Pain Management, Psychiatry +3 more·Pharmacy
Effective date
Mar 1, 2025
We identified it
Jun 21, 2026
Summary
Alaska Medicaid is updating their Preferred Drug List (PDL) effective March 1, 2025, and adding new prior authorization requirements for 21 medications including Auvelity, Hympavzi, and Skyrizi. Opioid prescriptions exceeding 150MME and stimulant medications for children under 6 will require prior authorization.
Action Required
Before March 1, 2025: Billing team must update prior authorization lists to include 21 new medications (Auvelity, Hympavzi, Skyrizi, Aucatzyl, Azmiro, Simlandi, Ziihera, Kebilidi, Opipza, Sacubitril-Valsartan, Tramadol 75mg, Tryngolza, Wezlana, Hydrocortisone 2.5% solution, Adalimumab-ADAZ, Ryzumvi, Emrosi, Attruby, Labetalol 400mg, Crenessity) and updated clinical criteria for Ocrevus/Ocrevus Zunovo. Providers must obtain prior authorization for opioid prescriptions exceeding 150MME and stimulant medications for children under 6. Visit Alaska Medicaid's prior authorization webpage to access new criteria and forms.